Written answers

Tuesday, 27 June 2017

Department of Health

Medicinal Products Reimbursement

Photo of John CurranJohn Curran (Dublin Mid West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

396. To ask the Minister for Health the position regarding the review being undertaken by his Department and the HSE following the decision of the NCPE in December 2016 to recommend against funding Respreeza; if the HSE or NCPE has met with a company (details supplied); if they reviewed the evidence presented in a second study published in a publication (details supplied); and if he will make a statement on the matter. [29930/17]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.